Oncogene alterations in non-small cell lung cancer with FGFR1 amplification-novel approach to stratify patients who benefit from FGFR inhibitors

Transl Lung Cancer Res. 2024 Mar 29;13(3):684-688. doi: 10.21037/tlcr-23-777. Epub 2024 Mar 8.

Authors

Hidenori Kitai¹, Hiromichi Ebi^{2

3}

Affiliations

¹ Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
² Division of Molecular Therapeutics, Aichi Cancer Center Research Institute, Nagoya, Japan.
³ Division of Advanced Cancer Therapeutics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

No abstract available

Keywords: FGFR inhibitor; Fibroblast growth factor receptor 1 (FGFR1); biomarker; squamous cell lung cancer (SQCLC).

Publication types

Editorial
Comment